About Mitochondrial membrane protein-associated neurodegeneration
Mitochondrial membrane protein-associated neurodegeneration is a rare disease catalogued by Orphanet (ORPHA:289560). It is associated with the C19ORF12 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mitochondrial membrane protein-associated neurodegeneration trials.
Search ClinicalTrials.gov for "Mitochondrial membrane protein-associated neurodegeneration" or filter by Orphanet code ORPHA:289560 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mitochondrial membrane protein-associated neurodegeneration trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mitochondrial membrane protein-associated neurodegeneration. Updated daily.